Alimta Injection

Alimta Injection is indicated for treatment of pleural mesothelioma & non-small cell lung cancer. Pemetrexed is the active compound present in this injection and has chemical formula C20H21N5O6 with molar mass of 427.411 g/mol. This injection is administered via intravenous route with protein binding ability of about 81% and elimination half life of 3.5 hours. It is a chemotherapy medication which works by inhibiting enzymes that are responsible for synthesis of purine, pyrimidine, & thymidine. Alimta Injection is highly effective in nature and assures targeted mode of action with long term effectiveness. It is not known to cause adverse health effects if administered under prescription.